Chain Bridge I terminates Phytanix Bio merger agreement; appoints RBSM as new auditor

Chain Bridge I

Mutual termination of Business Combination Agreement with Phytanix Bio effective April 7, 2025.
Frank, Rimerman dismissed as independent auditor on April 4, 2025; RBSM engaged for fiscal 2024.
Unaudited Q3 2024 financials to be restated due to $200,000 understatement of promissory note liability.
Material weakness in internal controls over financial reporting identified as of September 30, 2024.
Company working to file amended Form 10-Q and Form 10-K for fiscal 2024 with RBSM.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.